{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:29:13Z","timestamp":1793654953034,"version":"4.5.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cgh.2026.09.041","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:46:26Z","timestamp":1791319586000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Associations of Renin\u2013Angiotensin System Inhibitors and Calcium Channel Blockers With Liver Stiffness Dynamics and Long-Term Liver-Related Events in Metabolic Dysfunction\u2013Associated Steatotic Liver Disease"],"prefix":"10.1016","author":[{"given":"Xiao-Dong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-Fen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Up","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Cheuk-Fung Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Petta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Tsochatzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Boursier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Bugianesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wah-Kheong","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Romero-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Calleja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"de L\u00e9dinghen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Cast\u00e9ra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun J.","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Boon-Bee Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip Noel","family":"Newsome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Gao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Fournier-Poizat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Lai-Hung Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Armandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Pennisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elba","family":"Llop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Zoncap\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"de Saint-Loup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Gallego-Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Carrillo-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amon","family":"Asgharpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Kim-Jun Teh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Sau-Wai Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huapeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Targher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Wai-Sun Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4984-2631","authenticated-orcid":false,"given":"Ming-Hua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun J.","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Bugianesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Tsochatzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Boon-Bee Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Hagstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Boursier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Calleja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Romero-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip N.","family":"Newsome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Petta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Up","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"de L\u00e9dinghen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Wai-Sun Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wah-Kheong","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2026.09.041_bib1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S2468-1253(26)00011-7","article-title":"Global burden of metabolic dysfunction-associated steatotic liver disease, 1990-2023, and projections to 2050: a systematic analysis for the global Burden of Disease Study 2023","volume":"11","year":"2026","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.09.041_bib2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra2412865","article-title":"Metabolic dysfunction-associated steatotic liver disease","volume":"393","author":"Targher","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2026.09.041_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2026.156575","article-title":"Burden of metabolic diseases, 1990-2023, with forecasts to 2030 for the Asia-Pacific region","volume":"179","author":"Zhang","year":"2026","journal-title":"Metabolism"},{"key":"10.1016\/j.cgh.2026.09.041_bib4","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1007\/s00125-026-06726-1","article-title":"MASLD prevalence, incidence and global aspects","volume":"69","author":"Wild","year":"2026","journal-title":"Diabetologia"},{"key":"10.1016\/j.cgh.2026.09.041_bib5","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1007\/s11427-025-3193-9","article-title":"MASLD as a systemic metabolic disease: expanding the scope of cardiovascular-kidney-metabolic (CKM) syndrome","volume":"69","author":"Zhou","year":"2026","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.cgh.2026.09.041_bib6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.124.070535","article-title":"Cardiovascular-liver-metabolic health: recommendations in screening, diagnosis, and management of Metabolic dysfunction-associated steatotic liver disease in cardiovascular disease via modified Delphi approach","volume":"151","author":"Chew","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.cgh.2026.09.041_bib7","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cgh.2025.10.003","article-title":"Long-term glycemic control and the risk of liver stiffness progression and liver-related events in MASLD","volume":"24","author":"Zhou","year":"2026","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.09.041_bib8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41575-025-01045-z","article-title":"\u039cetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment","volume":"22","author":"Byrne","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.09.041_bib9","article-title":"Differential prevalence and prognostic value of metabolic syndrome components among patients with MASLD","volume":"6","author":"Pustjens","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.cgh.2026.09.041_bib10","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.cgh.2026.01.038","article-title":"Progression of liver fibrosis and liver-related event risk in MASLD at high cardiovascular risk","volume":"24","author":"Zhou","year":"2026","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.09.041_bib11","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.14309\/ajg.0000000000003274","article-title":"Cardiovascular risk from metabolic dysfunction-associated steatotic liver disease, cardiometabolic risk factor count, and their longitudinal changes: a nationwide cohort study","volume":"120","author":"Lee","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.09.041_bib12","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S2468-1253(24)00193-6","article-title":"Natural history and progression of metabolic dysfunction-associated steatotic liver disease","volume":"9","author":"Hagstr\u00f6m","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.09.041_bib13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S2468-1253(25)00323-1","article-title":"Pharmacotherapy for metabolic dysfunction-associated steatohepatitis: heart-liver co-management","volume":"11","author":"Zhou","year":"2026","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.09.041_bib14","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1016\/j.jhep.2025.07.007","article-title":"Optimize hypertension management to tackle the CVD burden in MASLD","volume":"83","author":"Kasper","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.09.041_bib15","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jhep.2025.11.010","article-title":"Further highlighting the importance of hypertension in MASLD","volume":"84","author":"Walia","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.09.041_bib16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jhep.2025.08.017","article-title":"Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD","volume":"84","author":"Zhou","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.09.041_bib17","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1016\/j.jhep.2025.08.024","article-title":"Reply to: \"optimize hypertension management to tackle the CVD burden in MASLD\"","volume":"83","author":"Ochoa-Allemant","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.09.041_bib18","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.09.041_bib19","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/j.gastro.2022.06.023","article-title":"AGA clinical practice update: diagnosis and management of nonalcoholic fatty liver disease in lean individuals: expert review","volume":"163","author":"Long","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.09.041_bib20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12072-024-10774-3","article-title":"The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease","volume":"19","author":"Eslam","year":"2025","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cgh.2026.09.041_bib21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/hep.32294","article-title":"Angiotensin-converting enzyme inhibitors prevent liver-related events in nonalcoholic fatty liver disease","volume":"76","author":"Zhang","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.09.041_bib22","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.14309\/ajg.0000000000002976","article-title":"The association between angiotensin-converting enzyme inhibitor or angiotensin receptor blocker exposure and key cirrhosis-related outcomes","volume":"120","author":"Wang","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.09.041_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/HEP.0000000000001333","article-title":"Renin-angiotensin-aldosterone system inhibitor use improves clinical outcomes in patients with metabolic dysfunction-associated steatotic liver diseases: target trial emulation using real-world data","volume":"83","author":"Ng","year":"2026","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.09.041_bib24","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/hep.27858","article-title":"A new mechanism of lipotoxicity: calcium channel blockers as a treatment for nonalcoholic steatohepatitis?","volume":"62","author":"Czaja","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.09.041_bib25","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cgh.2025.07.011","article-title":"Longitudinal changes in fibrosis markers: monitoring stiffness\/fibrosis progression and prognostic outcomes in MASLD","volume":"24","author":"Zhou","year":"2026","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.09.041_bib26","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jama.2024.1447","article-title":"Vibration-controlled transient elastography scores to predict liver-related events in steatotic liver disease","volume":"331","author":"Lin","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2026.09.041_bib27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/HEP.0000000000001645","article-title":"Cardiovascular-kidney-metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD","volume":"84","author":"Zhou","year":"2026","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.09.041_bib28","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.09.041_bib29","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/HEP.0000000000001015","article-title":"Liver stiffness progression in biopsy-proven metabolic dysfunction-associated steatotic disease among people with diabetes versus people without diabetes: a prospective multicenter study","volume":"81","author":"Huang","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.09.041_bib30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s12072-016-9705-x","article-title":"Renin-angiotensin system inhibitors and fibrosis in chronic liver disease: a systematic review","volume":"10","author":"Kim","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cgh.2026.09.041_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262411782","article-title":"Angiotensin-Converting enzyme inhibitors to prevent liver fibrosis in Metabolic dysfunction-associated steatotic liver disease: scientific speculation or an opportunity to improve real clinical practice?","volume":"26","author":"Seidita","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cgh.2026.09.041_bib32","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1097\/MJT.0b013e3181df8df5","article-title":"Hepatic fibrosis and the renin-angiotensin system","volume":"18","author":"Abbas","year":"2011","journal-title":"Am J Ther"},{"key":"10.1016\/j.cgh.2026.09.041_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111868","article-title":"The mechanisms of renin-angiotensin system in hepatocellular carcinoma: from the perspective of liver fibrosis, HCC cell proliferation, metastasis and angiogenesis, and corresponding protection measures","volume":"141","author":"Zhang","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.cgh.2026.09.041_bib34","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.27117","article-title":"Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis","volume":"60","author":"Granzow","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.09.041_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41575-026-01255-z","article-title":"Heart-liver co-management in MASLD: expert perspectives and recommendations from a multidisciplinary cardiometabolic framework","author":"Zhou","year":"2026","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.09.041_bib36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41575-018-0097-3","article-title":"Hepatic microcirculation and mechanisms of portal hypertension","volume":"16","author":"Gracia-Sancho","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.09.041_bib37","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ceca.2008.11.006","article-title":"Intracellular calcium signals regulate growth of hepatic stellate cells via specific effects on cell cycle progression","volume":"45","author":"Soliman","year":"2009","journal-title":"Cell Calcium"},{"key":"10.1016\/j.cgh.2026.09.041_bib38","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2022.5169","article-title":"Role of Ca(2+) channels in non-alcoholic fatty liver disease and their implications for therapeutic strategies (review)","volume":"50","author":"Chen","year":"2022","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.cgh.2026.09.041_bib39","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.4161\/15548627.2014.984268","article-title":"Calcium channel blockers as potential therapeutics for obesity-associated autophagy defects and fatty liver pathologies","volume":"10","author":"Park","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.cgh.2026.09.041_bib40","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jacc.2025.05.007","volume":"86","author":"Jones","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cgh.2026.09.041_bib41","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s41569-025-01199-y","article-title":"Cardiovascular-kidney-metabolic syndrome and MASLD: integrating medical perspectives","volume":"22","author":"Zhou","year":"2025","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cgh.2026.09.041_bib42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41575-025-01144-x","article-title":"Heart-liver co-management in MASLD: from concept to clinical practice","volume":"23","author":"Zhou","year":"2026","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.09.041_bib43","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/jch.12771","article-title":"Angiotensin system blockade combined with calcium channel blockers is superior to other combinations in cardiovascular protection with similar blood pressure reduction: a meta-analysis in 20,451 hypertensive patients","volume":"18","author":"Chi","year":"2016","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.cgh.2026.09.041_bib44","article-title":"A roadmap for heart-liver co-management in MASLD","volume":"13","author":"Zhou","year":"2026","journal-title":"Mil Med Res"},{"key":"10.1016\/j.cgh.2026.09.041_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70805","article-title":"CHAIN cohort: prospective multicenter Study of MASLD with serial liver stiffness assessments in cardiovascular care","volume":"46","author":"Zhou","year":"2026","journal-title":"Liver Int"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526007457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526007457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:59:27Z","timestamp":1793653167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356526007457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":45,"alternative-id":["S1542356526007457"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2026.09.041","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations of Renin\u2013Angiotensin System Inhibitors and Calcium Channel Blockers With Liver Stiffness Dynamics and Long-Term Liver-Related Events in Metabolic Dysfunction\u2013Associated Steatotic Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2026.09.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Gastroenterological Association Institute. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}